A new drug created by Cuban doctors may give hope to lung cancer victims, according to a story on CNN.com. The drug, named ClimaVax EGF has been in development for almost 20 years. Clinical trials have taken place in the UK, Canada and Cuba and over 700 patients have received the vaccine.
The vaccine extended the lives of terminal patients by four months, but some patients have had their lives extended for several years. The results were compared against those who only received conventional therapies like chemo and radiation. Younger patients appeared to have greater rates of success.
The drug encourages production of an antibody that inhibits EGF (epidermal growth factor), a substance in the body which drives lung cancer cell growth. It is hoped this treatment can be developed into something that can bring lung cancer under control, in the same way other chronic diseases are controlled by medication. Promising news.